Home › X-Linked Bulbo-Spinal Atrophy
X-Linked Bulbo-Spinal Atrophy clinical trials recruiting in the U.S.
6 studies for X-Linked Bulbo-Spinal Atrophy are recruiting participants at sites across the United States.
Recently updated studies
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Sep 29, 2026 · NCT07190300A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 3, 2026 · NCT07723248Androgen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen Insensitivity
RecruitingObservational studyHealthy volunteers welcome
Ages 8 to 99 · All sexes · Updated Aug 13, 2026 · NCT04708431Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 120 · Men · Updated Aug 13, 2026 · NCT04944940ALS/MND Natural History Study Data Repository
RecruitingObservational study
Ages 18 to 90 · All sexes · Updated May 20, 2026 · NCT05966038Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
RecruitingObservational study
All ages · All sexes · Updated May 29, 2025 · NCT01793168From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.